Innovation Ed
The FAME 3 Trial: quality of life after FFR-guided stenting compared with CABG surgery – ACC 2022
Video by PCR via YouTube
Go to Source
Luis Ortega-Paz interviews Frederik Zimmermann, first co-author of the FAME 3 Trial which he presented during the #ACC22 annual scientific sessions
View our full ACC 2022 coverage here: https://www.pcronline.com/News/Whats-new-on-PCRonline/2022/ACC-2022/PCR-ACC.22-Scientific-Sessions